Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1088 | 1030 | 1163 | 1259 | 1720 | 2856 |
Fund Return | 8.83% | 2.95% | 16.34% | 7.97% | 11.46% | 11.06% |
Place in category | 3904 | 3333 | 3814 | 2179 | 1421 | 461 |
% in Category | 57 | 50 | 63 | 44 | 38 | 21 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Capital Group New Perspective Funze | 14.45B | 8.68 | 2.60 | 10.05 | ||
Cap Group New Perspective lux N | 14.45B | 8.09 | 1.17 | - | ||
Capital Group New Perspective Fuzde | 14.45B | 8.70 | 2.61 | 10.05 | ||
Cap Group New Perspective lux C EUR | 14.45B | 9.09 | 3.44 | - | ||
Capital Group New Perspective Fuzge | 14.45B | 8.68 | 2.61 | 10.06 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
MS Global Brands Fund Ae | 21.59B | -0.03 | 2.26 | 8.14 | ||
MS Global Brands Fund AXe | 21.59B | -0.03 | 2.26 | 8.14 | ||
MS Global Brands Fund Be | 21.59B | -0.45 | 1.24 | 7.07 | ||
Investment Funds Global Brands Fuse | 21.59B | 0.39 | 3.20 | 9.04 | ||
MS Global Brands Fund BXe | 21.59B | -0.45 | 1.24 | 7.06 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Novo Nordisk B | DK0062498333 | 3.13 | 981.2 | -2.33% | |
Broadcom | US11135F1012 | 2.58 | 1,631.22 | -0.58% | |
Microsoft | US5949181045 | 2.37 | 457.00 | +0.06% | |
AstraZeneca | GB0009895292 | 1.99 | 12,074.0 | -1.87% | |
Safran | FR0000073272 | 1.98 | 201.20 | -0.45% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Buy | Strong Buy | Buy |
Technical Indicators | Strong Sell | Strong Buy | Strong Buy |
Summary | Neutral | Strong Buy | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review